Rodman & Renshaw Initiates Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $48

Futu NewsNov 5 20:31 · Ratings

Top Small-cap Stock Picks From Morgan Stanley Following the Group's Upgrade to Neutral

Seeking AlphaOct 22 02:52

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

BenzingaOct 8 21:03

Bicara Therapeutics Initiated at Overweight by Morgan Stanley

Dow JonesOct 8 19:35 · Ratings

Cantor Fitzgerald Initiates Coverage on Bicara Therapeutics With Overweight Rating

MT NewswiresOct 8 19:23

Bicara Therapeutics Analyst Ratings

BenzingaOct 8 19:21 · Ratings